| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 16:24:55 UTC |
|---|
| Updated at | 2022-05-11 16:24:55 UTC |
|---|
| NP-MRD ID | NP0086575 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 2-Hydroxyadenine |
|---|
| Description | 2-Hydroxyadenine, also known as isoguanine or 2-OH-ade, belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. 2-Hydroxyadenine was first documented in 1976 (PMID: 1018622). 2-Hydroxyadenine is a moderately basic compound (based on its pKa) (PMID: 14615972) (PMID: 14709079) (PMID: 8841637) (PMID: 9726918) (PMID: 1324197) (PMID: 9726022). |
|---|
| Structure | InChI=1S/C5H5N5O/c6-3-2-4(8-1-7-2)10-5(11)9-3/h1H,(H4,6,7,8,9,10,11) |
|---|
| Synonyms | | Value | Source |
|---|
| 2-Oxoadenine | ChEBI | | 6-Amino-1,3-dihydro-2H-purin-2-one | ChEBI | | 6-Amino-3,7-dihydro-purin-2-one | ChEBI | | 6-Amino-3,9-dihydro-2H-purin-2-one | ChEBI | | 6-Amino-7H-purin-2-ol | ChEBI | | 6-Amino-9H-purin-2-ol | ChEBI | | 2-Hydroxy-6-aminopurine | HMDB | | 2-Oxyadenine | HMDB | | 6-Amino-2-hydroxypurine | HMDB | | 6-Amino-3,7(9)-dihydro-purin-2-one | HMDB | | Isoguanine | HMDB | | 2-OH-Ade | HMDB | | Crotonoside | HMDB | | 2-Hydroxyadenine | ChEBI |
|
|---|
| Chemical Formula | C5H5N5O |
|---|
| Average Mass | 151.1261 Da |
|---|
| Monoisotopic Mass | 151.04941 Da |
|---|
| IUPAC Name | 6-amino-7H-purin-2-ol |
|---|
| Traditional Name | 2-hydroxy-6-aminopurine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | NC1=NC(O)=NC2=C1NC=N2 |
|---|
| InChI Identifier | InChI=1S/C5H5N5O/c6-3-2-4(8-1-7-2)10-5(11)9-3/h1H,(H4,6,7,8,9,10,11) |
|---|
| InChI Key | DRAVOWXCEBXPTN-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Imidazopyrimidines |
|---|
| Sub Class | Purines and purine derivatives |
|---|
| Direct Parent | 6-aminopurines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 6-aminopurine
- Aminopyrimidine
- Hydroxypyrimidine
- Pyrimidine
- Imidolactam
- Azole
- Imidazole
- Heteroaromatic compound
- Azacycle
- Organopnictogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Pettit GR, Ode RH, Coomes RM, Ode SL: Antineoplastic agents. 42. The butterfly, Prioneris thestylis. Lloydia. 1976 Sep-Oct;39(5):363-7. [PubMed:1018622 ]
- Rogstad KN, Jang YH, Sowers LC, Goddard WA 3rd: First principles calculations of the pKa values and tautomers of isoguanine and xanthine. Chem Res Toxicol. 2003 Nov;16(11):1455-62. doi: 10.1021/tx034068e. [PubMed:14615972 ]
- Blas JR, Luque FJ, Orozco M: Unique tautomeric properties of isoguanine. J Am Chem Soc. 2004 Jan 14;126(1):154-64. doi: 10.1021/ja036806r. [PubMed:14709079 ]
- Kamiya H, Kasai H: 2-Hydroxyadenine (isoguanine) as oxidative DNA damage: its formation and mutation inducibility. Nucleic Acids Symp Ser. 1995;(34):233-4. [PubMed:8841637 ]
- Yang XL, Sugiyama H, Ikeda S, Saito I, Wang AH: Structural studies of a stable parallel-stranded DNA duplex incorporating isoguanine:cytosine and isocytosine:guanine basepairs by nuclear magnetic resonance spectroscopy. Biophys J. 1998 Sep;75(3):1163-71. doi: 10.1016/S0006-3495(98)74035-4. [PubMed:9726918 ]
- Olinski R, Zastawny T, Budzbon J, Skokowski J, Zegarski W, Dizdaroglu M: DNA base modifications in chromatin of human cancerous tissues. FEBS Lett. 1992 Sep 7;309(2):193-8. doi: 10.1016/0014-5793(92)81093-2. [PubMed:1324197 ]
- Arashidani K, Iwamoto-Tanaka N, Muraoka M, Kasai H: Genotoxicity of ribo- and deoxyribonucleosides of 8-hydroxyguanine, 5-hydroxycytosine, and 2-hydroxyadenine: induction of SCE in human lymphocytes and mutagenicity in Salmonella typhimurium TA 100. Mutat Res. 1998 Jul 17;403(1-2):223-7. doi: 10.1016/s0027-5107(98)00086-4. [PubMed:9726022 ]
|
|---|